The Society of MSK Campaign
The Campaign is The Society's oldest fundraising effort. Each year, MSK's Chief Physician Executive identifies a critical institutional priority for the Campaign to support, and the collective generosity of The Society members and donors provides crucial funding to advance this work.
The 2025–2026 Campaign: Finding Tomorrow’s Treatments Today
Support MSK investigators who are expanding access to pioneering clinical trials and accelerating the development of lifesaving cancer therapies.
Driving breakthroughs in cancer research and care
MSK has made extraordinary strides in translating laboratory discoveries into life-changing cancer care, and The Society of MSK has long championed innovations that transform treatment. This year’s campaign presents a powerful opportunity to build on that legacy and fuel one of the most impactful drivers of progress in cancer care: clinical trials.
Accelerating progress
For many people with cancer, clinical trials offer the best opportunities for healing and survival. A gift to The Society of MSK’s 2025–2026 Campaign will expand patient access to MSK clinical trials, speed the development of novel drugs, and bring renewed hope to people with cancer around the world.
Your support turns pioneering discovery into life-changing care.
Research supported by past Society Campaigns
Since 1946, The Society of MSK has funded critical research projects, ensuring that patients have access to life-changing cancer care. This support has been essential to MSK’s ability to thrive without limits and help people worldwide. Read about past Campaigns below.
Treating teens and young adults
Colorectal and gastrointestinal cancer diagnoses are rising worldwide for people under 50, and MSK is at the forefront of responding to this global health crisis by advancing leading-edge research and patient care.
New therapies for lymphoma
Home to one of the world’s largest and most innovative research and clinical trial programs focused on lymphoma, MSK is uniquely positioned to uncover new cancer therapies that improve outcomes for people with this disease.
Breakthroughs in immunotherapy
MSK is a global leader in immunotherapy, the revolutionary approach that uses the body’s own immune system to fight cancer. Our scientists are exploring new ways to enable more people with cancer to benefit from this novel treatment.
Pancreatic cancer care advances
Pancreatic cancer is often not detected until it has reached a late stage. Through innovative research, MSK scientists are transforming cancer care for people with pancreatic cancer around the world.
Join us in making this year’s Society Campaign a success.